Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-24-000012 General Corporate
Debt relative to revenue 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
147.23% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.69% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-6.40% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
13.05% · CORE · VALID
Inventory pressure 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
77.55% · OPTIONAL · VALID
Gross margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
35.58% · CORE · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.02% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.22% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.66% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 36.91%
Current 147.23%
Delta 110.32% Capex Intensity Increased
Previous 1.57%
Current 1.69%
Delta 0.12% Cash Generation Decreased
Previous 15.75%
Current -6.40%
Delta -22.15% Inventory Pressure Increased
Previous 17.92%
Current 77.55%
Delta 59.62% Margin Decreased
Previous 37.51%
Current 35.58%
Delta -1.92% Profitability Decreased
Previous 17.03%
Current 14.02%
Delta -3.01% R And D Intensity Increased
Previous 3.01%
Current 3.22%
Delta 0.21% Sbc Intensity Increased
Previous 0.59%
Current 0.66%
Delta 0.07% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.